National Pharmaceutical Industries Co. (SAOG), OMAN
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- OMACID chewable tablet
- OMACID oral suspension
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- ORS powder for oral solution
- A10 - Antidiabéticos
- GLIPOM tablet 5 mg
- OMFORMIN film-coated tablet 500 mg
- C07 - Betabloqueantes
- BETATEN film-coated tablet 100 mg
- BETATEN film-coated tablet 50 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- OMACE tablet 10 mg
- OMACE tablet 20 mg
- OMACE tablet 5 mg
- C10 - Agentes modificadores de los lípidos
- VISCOR film-coated tablet 20 mg
- G04 - Urológicos
- ALKA UR effervescent granules
- J01 - Antibacterianos para uso sistémico
- OMACEPH capsule, hard 250 mg
- OMACEPH capsule, hard 500 mg
- OMACEPH powder for oral suspension 125 mg/5 ml
- OMACILLIN capsule, hard 250 mg
- OMACILLIN capsule, hard 500 mg
- OMACILLIN powder for oral suspension 125 mg/5 ml
- OMACILLIN powder for oral suspension 500 mg/5 ml
- OMACIP film-coated tablet 250 mg
- OMACIP film-coated tablet 500 mg
- OMATHROCIN film-coated tablet 250 mg
- OMATHROCIN oral drops, solution 100 mg/2.5 ml
- OMATHROCIN oral suspension 200 mg/5 ml
- M01 - Antiinflamatorios y antirreumáticos
- OMAFEN film-coated tablet 400 mg
- N02 - Analgésicos
- OMOL EXTRA tablet
- OMOL oral drops, solution 100 mg/ml
- OMOL syrup 120 mg/5 ml
- OMOL tablet 500 mg
- R06 - Antihistamínicos para uso sistémico
- LOHIST syrup 0.1%
- LOHIST tablet 10 mg
- OMCET film-coated tablet 10 mg
- OMCET oral drops, solution 10 mg/ml
- OMCET oral solution 5 mg/5 ml
- OMVIL syrup 2 mg/5 ml
- OMVIL tablet 4 mg